ALX Oncology Holdings Inc (ALXO): Weighted Average Diluted Shares
53.66M
Year ended 2025-12-31
+9.7%
3-year compound annual growth
+23.8%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 53.66M | +2.8% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | 52.17M | +21.4% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | 42.99M | +5.6% | 2026-03-09, From 2023-01-01 |
| 2022-12-31 | 40.70M | +1.0% | 2025-03-06, From 2022-01-01 |
| 2021-12-31 | 40.31M | +118.1% | 2024-03-07, From 2021-01-01 |
| 2020-12-31 | 18.49M | n/a | 2023-03-09, From 2020-01-01 |